Um unsere Website nutzerfreundlicher, effektiver und sicherer zu machen, verwenden wir Cookies. Durch die weitere Nutzung der Website stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies erhalten Sie in unserer Datenschutzerklärung.

Mehr Informationen
Info

Herzinfarktregister Brandenburg

Herzinfarktregister Brandenburg

Suchen

2. Publikationen

Publikationen 2023

  1. Andresen H, Pagonas N, Eisert M, Patschan D, Nordbeck P, Buschmann I, Sasko B, Ritter O., Defibrillator exchange in the elderly, Heart Rhythm O2. 2023 May 13;4(6):382-390. doi: 10.1016/j.hroo.2023.05.001. eCollection 2023 Jun. PMID: 37361620
  2. Pagonas N, Sasko B, Ritter O., Managing hypertension in the future: a multifactorial approach. Eur J Prev Cardiol. 2023 Jan 11;30(1):46-47. doi: 10.1093/eurjpc/zwac238.
  3. Patschan D, Patschan S, Matyukhin I, Hoffmeister M, Lauxmann M, Ritter O, Dammermann W., Metabolomics in Acute Kidney Injury: The Experimental Perspective. J Clin Med Res. 2023 Jun;15(6):283-291. doi: 10.14740/jocmr4913. Epub 2023 Jun 29.
  4. Patschan D, Patschan S, Matyukhin I, Ritter O, Dammermann W.Metabolomics in Acute Kidney Injury: The Clinical Perspective. J Clin Med. 2023 Jun 16;12(12):4083. doi: 10.3390/jcm12124083.
  5. Li K, Kratzmann V, Dai M, Gatzke N, Rocic P, Bramlage P, Grisk O, Lubomirov LT, Hoffmeister M, Lauxmann MA, Ritter O, Buschmann E, Bader M, Persson AB, Buschmann I, Hillmeister P.Angiotensin receptor-neprilysin inhibitor improves coronary collateral perfusion. Front Cardiovasc Med. 2023 Feb 3;9:981333. doi: 10.3389/fcvm.2022.981333. eCollection 2022.
  6. Patschan D, Erfurt S, Oess S, Lauxmann MA, Patschan S, Ritter O, Hoffmeister M. Biomarker-based prediction of survival and recovery of kidney function in acute kidney injury, Kidney Blood Press Res. 2023 Feb 9. doi: 10.1159/000528633. Online ahead of print.
  7. Jänsch M, Lubomirov LT, Trum M, Williams T, Schmitt J, Schuh K, Qadri F, Maier LS, Bader M, Ritter O. Inducible over-expression of cardiac Nos1ap causes short QT syndrome in transgenic mice, FEBS Open Bio. 2023 Jan;13(1):118-132. doi: 10.1002/2211-5463.13520. Epub 2022 Nov 27.
  8. Pagonas N, Seibert FS, Liebisch G, Seidel M, Giannakopoulos T, Sasko B, Ritter O, Babel N, Westhoff TH. Association of plasma propionate concentration with coronary artery disease in a large cross-sectional study. Front Cardiovasc Med. 2023 Feb 1;10:1063296. doi: 10.3389/fcvm.2023.1063296. eCollection 2023.
  9. Li K, Dai M, Sacirovic M, Zemmrich C, Pagonas N, Ritter O, Grisk O, Lubomirov LT, Lauxmann MA, Bramlage P, Persson AB, Buschmann E, Buschmann I, Hillmeister P. Leukocyte telomere length and mitochondrial DNA copy number associate with endothelial function in aging-related cardiovascular disease. Front Cardiovasc Med. 2023 Jun 5;10:1157571. doi: 10.3389/fcvm.2023.1157571. eCollection 2023.
  10. Merz S, Jaehn P, Pischon T, Fischer B, Wirkner K, Rach S, Guenther K, Obi N, Holmberg C; AdvanceGender Study Group. Investigating people's attitudes towards participating in longitudinal health research: an intersectionality-informed perspective. Int J Equity Health. 2023 Jan 31;22(1):23. doi: 10.1186/s12939-022-01807-0.

Publikationen 2022

  1. Jaehn P, Andresen-Bundus H, Bergholz A, Pagonas N, Hauptmann M, Neugebauer EA, Holmberg C, Ritter O, Sasko B. Contextualising the association of socioeconomic deprivation with hospitalisation rates of myocardial infarction in a rural area in eastern Germany, Rural and Remote Health, Rural Remote Health. 2022 Apr;22(2):6658. doi: 0.22605/RRH6658. Epub 2022 Apr 8.
  2. Wang, C.; Enssle, J.; Pietzner, A.; Schmöcker, C.; Weiland, L.; Ritter, O.; Jaensch, M.; Elbelt, U.; Pagonas, N.; Weylandt, K.H, Essential Polyunsaturated Fatty Acids in Blood from Patients with and without Catheter-Proven Coronary Artery Disease; Int. J. Mol. Sci. 2022, 23, 766.
  3. Sasko B, Jaehn P, Müller R, Andresen H, Müters S, Holmberg C, Ritter O, Pagonas N, Understanding the importance of social determinants and rurality for the long-term outcome after acute myocardial infarction: study protocol for a single-centre cohort study, BMJ Open, 2022 Apr 15;12(4):e056888. doi: 10.1136/bmjopen-2021-056888
  4. Ghafoor H, Nordbeck P, Ritter O, Pauli P, Schulz SM., Can Religiosity and Social Support Explain Effects of Trait Emotional Intelligence on Health-Related Quality of Life: A Cross-Cultural Study, J Relig Health. 2022 Feb;61(1):158-174. doi: 10.1007/s10943-020-01163-9. Epub 2021 Jan 7.PMID: 33415603
  5. Lubomirov LT, Jänsch MH, Papadopoulos S, Schroeter MM, Metzler D, Bust M, Hescheler J, Grisk O, Ritter O, Pfitzer G., Senescent murine femoral arteries undergo vascular remodelling associated with accelerated stress-induced contractility and reactivity to nitric oxide, Basic Clin Pharmacol Toxicol. 2022 Jan;130(1):70-83. doi: 10.1111/bcpt.13675. Epub 2021 Nov 11.PMID: 34665520
  6. Ding WY, Potpara TS, Blomström-Lundqvist C, Boriani G, Marin F, Fauchier L, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry, Eur J Clin Invest. 2022 Jan 9:e13745. doi: 10.1111/eci.13745. Online ahead of print.PMID: 35000206
  7. Patschan D, Marahrens B, Jaensch M, Patschan S, Ritter O. Experimental Cardiorenal Syndrome Type 3: What Is Known so Far?, J Clin Med Res. 2022 Jan;14(1):22-27. doi: 10.14740/jocmr4639. Epub 2022 Jan 29.PMID: 35211213
  8. Hillmeister P, Nagorka S, Gatzke N, Dülsner A, Li K, Dai M, Bondke Persson A, Lauxmann MA, Jaurigue J, Ritter O, Bramlage P, Buschmann E, Buschmann I., Angiotensin-converting enzyme inhibitors stimulate cerebral arteriogenesis, Acta Physiol (Oxf). 2022 Feb;234(2):e13732. doi: 10.1111/apha.13732. Epub 2021 Oct 2.PMID: 34555240
  9. Zeymer U, Toelg R, Wienbergen H, Hobbach HP, Cuneo A, Bekeredjian R, Ritter O, Hailer B, Hertting K, Hennersdorf M, Scholtz W, Lanzer P, Mudra H, Schwefer M, Schwimmbeck PL, Liebetrau C, Thiele H, Claas C, Riemer T, Zahn R. Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany, Herz. 2022 Mar 3. doi: 10.1007/s00059-022-05099-6. Online ahead of print.PMID: 35243515
  10. Drubel K, Marahrens B, Ritter O, Patschan D., Kidney-Related Outcome in Cardiorenal Syndrome Type 3, Int J Nephrol. 2022 Feb 7;2022:4895434. doi: 10.1155/2022/4895434. eCollection 2022.PMID: 35178254
  11. Jaehn P, Sasko B, Holmberg C, Hoffmann S, Spallek J, Kelesidis T, Westhoff TH, Ritter O, Pagonas N, Levels of high-density lipoprotein lipid peroxidation according to spatial socioeconomic deprivation and rurality among patients with coronary artery disease, European Journal of Preventive Cardiology, May 2022
  12. Füller D, Jaehn P, Andresen-Bundus H, Pagonas N, Holmberg C, Christ M, Ritter O, Sasko B, Impact of the Educational Level on Non-Fatal Health Outcomes following Myocardial Infarction, Curr Probl Cardiol. 2022 Jul 30;47(11):101340. doi: 10.1016/j.cpcardiol.2022.101340.

Publikationen 2021

  1. Sasko B., Patschan D., Nordbeck P., Seidlmayer L., Andresen H., Jänsch M., Bramlage P., Ritter O., Pagonas N., Secondary Prevention of Potentially Life-Threatening Arrhythmia Using Implantable Cardioverter Defibrillators in Patients with Biopsy-Proven Viral Myocarditis and Preserved Ejection Fraction, Cardiology, February 05, 2021, doi.org/10.1159/000511120
  2. Reinwald M, Deckert PM, Ritter O, Andresen H, Schreyer AG, Weylandt KH, Dammermann W, Lüth S. Prevalence and Course of IgA and IgG Antibodies against SARS-CoV-2 in Healthcare Workers during the First Wave of the COVID-19 Outbreak in Germany: Interim Results from an Ongoing Observational Cohort Study. Healthcare (Basel). 2021;9(5).
  3. Dihazi H, Schwarze K, Patschan S, Müller GA, Ritter O, Zeisberg M, Patschan D. PAC-Mediated AKI Protection Is Critically Mediated but Does Not Exclusively Depend on Cell-Derived Microvesicles. Int J Nephrol. 2021;2021:8864183.
  4. Ritter O, Kararigas G. In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact. Mayo Clin Proc. 2021;96(3):821-822.
  5. Andresen H, Sasko B, Patschan D, Pagonas N, Ritter O. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report. J Med Case Rep. 2021;15(1):243.
  6. Ghafoor H, Nordbeck P, Ritter O, Pauli P, Schulz SM. Can Religiosity and Social Support Explain Effects of Trait Emotional Intelligence on Health-Related Quality of Life: A Cross-Cultural Study. J Relig Health. 2021.
  7. Markakis K, Pagonas N, Georgianou E, Zgoura P, Rohn BJ, Bertram S, Seidel M, Bettag S, Trappe HJ, Babel N, Westhoff TH, Seibert FS. Feasibility of non-invasive measurement of central blood pressure and arterial stiffness in shock. Eur J Clin Invest. 2021;e13587.
  8. Seidel M, Pagonas N, Seibert FS, Bauer F, Rohn B, Vlatsas S, Mühlberger D, Nina B, Westhoff TH. The differential impact of aerobic and isometric handgrip exercise on blood pressure variability and central aortic blood pressure. J Hypertens. 2021;39(7):1269-1273.
  9. Asmus K, Erfurt S, Ritter O, Patschan S, Patschan D. AKI Epidemiology and Outcomes: A Retrospective Cohort Study from the Prenephrology Era. Int J Nephrol. 2021;2021:5549316.
  10. Erfurt S, Hoffmeister M, Oess S, Asmus K, Ritter O, Patschan S, Patschan D. Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification?; J Circ Biomark. 2021 Nov 30;10:20-25.
  11. Hillmeister P, Nagorka S, Gatzke N, Dülsner A, Li K, Dai M, Bondke Persson A, Lauxmann MA, Jaurigue J, Ritter O, Bramlage P, Buschmann E, Buschmann I., Angiotensin-converting enzyme inhibitors stimulate cerebral arteriogenesis.Acta Physiol (Oxf). 2021 Sep 23:e13732.
  12. Lubomirov LT, Jänsch MH, Papadopoulos S, Schroeter MM, Metzler D, Bust M, Hescheler J, Grisk O, Ritter O, Pfitzer G. Senescent murine femoral arteries undergo vascular remodelling associated with accelerated stress-induced contractility and reactivity to nitric oxide, Basic Clin Pharmacol Toxicol. 2022 Jan;130(1):70-83. doi: 10.1111/bcpt.13675. Epub 2021 Nov 11.
  13. Seckinger D, Ritter O, Patschan D., Risk factors and outcome variables of cardiorenal syndrome type 1 from the nephrologist's perspective. Int Urol Nephrol. 2021 Oct 28.
  14. Greffin K, Muehlan H, van den Berg N, Hoffmann W, Ritter O, Oeff M, Schomerus G, Schmidt S. Setting-Sensitive Conceptualization and Assessment of Quality of Life in Telemedical Care-Study Protocol of the Tele-QoL Project, Int J Environ Res Public Health. 2021 Oct 5;18(19):10454.
  15. Greffin K, Schmidt S, van den Berg N, Hoffmann W, Ritter O, Oeff M, Schomerus G, Muehlan H. Same same-but different: using qualitative studies to inform concept elicitation for quality of life assessment in telemedical care: a request for an extended working model, Health Qual Life Outcomes. 2021 Jul 5;19(1):175.
  16. Seibert FS, Heringhaus A, Pagonas N, Rohn B, Bauer F, Trappe HJ, Landmesser U, Babel N, Westhoff TH. Dickkopf-3 in the prediction of contrast media induced acute kidney injury,J Nephrol. 2021 Jun;34(3):821-828.

Publikationen 2020

  1. Patschan D, Schwarze K, Tampe B, Becker JU, Hakroush S, Ritter O, Patschan S, Müller GA; Constitutive Atg5 overexpression in mouse bone marrow endothelial progenitor cells improves experimental acute kidney injury; BMC Nephrol. 2020; 21: 503. Published online 2020 Nov 23. doi: 10.1186/s12882-020-02149-1
  2. Patschan S, Bothmann L, Patschan D, Henze E, Schmalz G, Ritter O., Ziebolz D; Association of cytokine patterns and clinical/laboratory parameters, medication and periodontal burden in patients with rheumatoid arthritis (RA); Odontology. 2020; 108(3): 441–449. Published online 2020 Apr 16. doi: 10.1007/s10266-020-00517-9
  3. Sasko B, Ritter O, Bramlage P, Riediger F; Late left atrial appendage closure device displacement and massive thrombus formation: a case report; Eur Heart J Case Rep. 2020 Jun; 4(2): 1–5. Published online 2020 Feb 20. doi: 10.1093/ehjcr/ytaa014
  4. Ritter O, Kararigas G; Sex-Biased Vulnerability of the Heart to COVID-19; Mayo Clin Proc. 2020 Nov; 95(11): 2332–2335. Published online 2020 Sep 18. doi: 10.1016/j.mayocp.2020.09.017
  5. Seibert FS, Heringhaus A, Pagonas N, Rudolf H, Rohn B, Bauer F, Timmesfeld N, Trappe HJ, Babel N, Westhoff TH; Biomarkers in the prediction of contrast media induced nephropathy – the BITCOIN study; PLoS One. 2020; 15(7): e0234921. Published online 2020 Jul 16. doi: 10.1371/journal.pone.0234921
  6. Pagonas N, Bauer F, Zappe L, Seibert FS, Rohn B, Klimek C, Wirth R, Gotzmann M, Babel N, Westhoff TH; Hemodynamic Effects of a Multidisciplinary Geriatric Rehabilitation Program; Clin Interv Aging. 2020; 15: 1035–1043. Published online 2020 Jun 30. doi: 10.2147/CIA.S239844
  7. Seibert FS, Heringhaus A, Pagonas N, Rohn B, Bauer F, Trappe HJ, Landmesser U, Babel N, Westhoff TH. Dickkopf-3 in the prediction of contrast media induced acute kidney injury. J Nephrol. 2020 Dec 4. doi: 10.1007/s40620-020-00910-1. Online ahead of print. PMID: 33275197
  8. Patschan D, Patschan S, Ritter O. Chronic Metabolic Acidosis in Chronic Kidney Disease. Kidney Blood Press Res. 2020;45(6):812-822. doi: 10.1159/000510829. Epub 2020 Dec 2. PMID: 33264780 Free article. Review
  9. Matyukhin I, Patschan S, Ritter O, Patschan D. Etiology and Management of Acute Metabolic Acidosis: An Update. Kidney Blood Press Res. 2020;45(4):523-531. doi: 10.1159/000507813. Epub 2020 Jul 14. PMID: 32663831 Free article. Review
  10. Proietti M, Lip GYH, Laroche C, Fauchier L, Marin F, Nabauer M, Potpara T, Dan GA, Kalarus Z, Tavazzi L, Maggioni AP, Boriani G; ESC-EORP Atrial Fibrillation General Long-Term Registry Investigators Group. Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry. Europace. 2020 Oct 2:euaa274. doi: 10.1093/europace/euaa274. Online ahead of print. PMID: 33006613

Zurück